Consensus Doximity, Inc.

Stocks

DOCS

US26622P1075

Software

Market Closed - NYSE 01:00:03 06/11/2026 +04			5-day change	1st Jan Change
33.18 ^USD	-4.30%		-1.34%	-25.07%

11-06	(DOCS) Doximity Expects Fiscal 2027 Revenue Range $678M-$683M, vs. FactSet Est of $677.6M	MT
11-06	Doximity Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; Sets Q3 Guidance	MT

Evolution of the Average Target: Doximity, Inc.

Evolution of the Target Price: Doximity, Inc.

Changes in Analyst Recommendations: Doximity, Inc.

1f.wR_MivIlEvDSJw_7o3zsJNVJkLd0QG3g-WJLmu9gQLE.pnaP7cJmdaWcQ2SyzgzZb5AN6uUOHwGIqDoOroZZdfe2fqncoWRzqKhhTg~b122cca3f2545ee953d22fe5ed516820

Analysts' recommendations: Doximity, Inc.

10-20	BofA Securities Adjusts Price Target on Doximity to $23 From $20, Maintains Underperform Rating	MT
08-13	Truist Adjusts Price Target on Doximity to $24 From $19, Maintains Hold Rating	MT
08-10	Wells Fargo Downgrades Doximity to Underweight From Equalweight, Price Target is $18	MT
08-07	Doximity Raises FY27 Outlook on AI Search Momentum, RBC Says	MT
06-29	Doximity's AI Pivot Clouds Growth Trajectory, May Face Execution Risks, BofA Says in Downgrade	MT
06-29	BofA Downgrades Doximity to Underperform From Buy, Cuts Price Target to $20 From $38	MT
06-29	Doximity Facing Limited Clarity on AI Projects, BofA Says	MT
06-29	BofA Downgrades Doximity to Underperform From Buy, Price Target is $20	MT
06-25	Doximity Faces Continued Softness in Pharma Marketing Spending, RBC Capital Markets Says	MT
05-15	Barclays Downgrades Doximity to Equalweight From Overweight, Adjusts Price Target to $20 From $38	MT
05-15	Analyst recommendations: Amex, Applied Materials, Doximity, Fox, Broadcom…
05-14	Doximity Growth Slowdown, Weak Outlook Raise Concerns, Morgan Stanley Says	MT
05-14	KeyBanc Downgrades Doximity to Sector Weight From Overweight	MT
05-14	Jefferies Downgrades Doximity to Hold From Buy, Adjusts Price Target to $19 From $51	MT
05-14	Wells Fargo Downgrades Doximity to Equal Weight From Overweight, Cuts Price Target to $18 From $32	MT
05-14	Baird Downgrades Doximity to Neutral From Outperform, Adjusts Price Target to $18 From $40	MT
05-14	BTIG Downgrades Doximity to Neutral From Buy	MT
05-14	Morgan Stanley Cuts Price Target on Doximity to $35 From $49, Keeps Overweight Rating	MT
05-14	Truist Securities Adjusts Price Target on Doximity to $19 From $29, Maintains Hold Rating	MT
05-14	Analyst recommendations: Doximity, Reddit, Cisco, Whirlpool, Caterpillar…
05-11	Analyst recommendations: Biomarin Pharmaceuticals, Walt Disney, Apollo Global Management, Datadog, Roku…
04-20	Truist Downgrades Doximity to Hold From Buy, Cuts Price Target to $29 From $37	MT
04-20	Analyst recommendations: Doximity, Okta, Bloom Energy, Intel, Whirlpool…
04-13	Analyst recommendations: ConocoPhillips, Hewlett Packard Enterprise, Nike, Occidental Petroleum, T-Mobile, Ge Vernova…
04-08	Doximity Shares Fall After Evercore Downgrade	MT

More recommendations

Application Software

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DOXIMITY, INC.					-6.24%
	MICROSOFT CORPORATION					+18.14%
	PALANTIR TECHNOLOGIES INC.					+40.63%
	ORACLE CORPORATION					+104.46%
	PALO ALTO NETWORKS, INC.					+26.65%
	SAP SE					+10.75%
	CROWDSTRIKE HOLDINGS, INC.					+14.39%
	SERVICENOW, INC.					+51.12%
	ADOBE INC.					+8.87%
	FORTINET, INC.					+18.81%
	Average					+28.76%
	Weighted average by Cap.					+25.28%